<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Reckitt Benckiser Group Plc — News on 6ix</title>
<link>https://6ix.com/company/reckitt-benckiser-group-plc</link>
<description>Latest news and press releases for Reckitt Benckiser Group Plc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Wed, 22 Apr 2026 06:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/reckitt-benckiser-group-plc" rel="self" type="application/rss+xml" />
<item>
<title>Q1 RESULTS 2026</title>
<link>https://6ix.com/company/reckitt-benckiser-group-plc/news/q1-results-2026</link>
<guid isPermaLink="true">https://6ix.com/company/reckitt-benckiser-group-plc/news/q1-results-2026</guid>
<pubDate>Wed, 22 Apr 2026 06:00:00 GMT</pubDate>
<description>Reckitt Benckiser Group PLC reported first-quarter 2026 results with Core Reckitt achieving 1.3% like-for-like net revenue growth, totaling £2,598 million, driven by 7.6% growth in Emerging Markets to £1,087 million, though Europe saw a 4.2% decline to £873 million and North America a 0.9% decline to £638 million. Excluding seasonal over-the-counter products, Core Reckitt's like-for-like net revenue grew by 3.1%. The company maintained its full-year like-for-like net revenue outlook for Core Rec</description>
</item>
<item>
<title>Reckitt Accelerates Innovation with NIQ AI Insights, reporting up to 65% faster research</title>
<link>https://6ix.com/company/reckitt-benckiser-group-plc/news/reckitt-accelerates-innovation-with-niq-ai-insights-reporting-up-to-65percent-faster-research-1</link>
<guid isPermaLink="true">https://6ix.com/company/reckitt-benckiser-group-plc/news/reckitt-accelerates-innovation-with-niq-ai-insights-reporting-up-to-65percent-faster-research-1</guid>
<pubDate>Tue, 07 Apr 2026 10:30:00 GMT</pubDate>
<description>CHICAGO, April 07, 2026--NIQ (NYSE: NIQ), a global leader in consumer intelligence, today shared new results from Reckitt’s use of NIQ BASES AI Screener, demonstrating how AI-powered insights and synthetic data are transforming innovation speed and effectiveness. The case study highlights how Reckitt has accelerated concept development while improving performance outcomes—bringing more relevant products to market, faster.</description>
</item>
<item>
<title>FINISH® LAUNCHES NEW FINISH ULTIMATE QUANTUM WITH IMMERSIVE, GRANDMA-LED COOKBOOK CLUB</title>
<link>https://6ix.com/company/reckitt-benckiser-group-plc/news/finishr-launches-new-finish-ultimate-quantum-with-immersive-grandma-led-cookbook-club</link>
<guid isPermaLink="true">https://6ix.com/company/reckitt-benckiser-group-plc/news/finishr-launches-new-finish-ultimate-quantum-with-immersive-grandma-led-cookbook-club</guid>
<pubDate>Thu, 19 Mar 2026 13:00:00 GMT</pubDate>
<description>Today, Finish®, a Reckitt brand and a global leader in the dishwasher detergents category, announced the launch of Finish Ultimate Quantum, a breakthrough dishwashing detergent with Finish's most advanced formula yet. The new Finish Ultimate Quantum delivers 50% more cleaning power*** at a lower cost per wash than a market leading brand**, helping households achieve a superior clean without compromising value**.</description>
</item>
<item>
<title>RECKITT CATALYST AND SERENA WILLIAMS HEADLINE SXSW® WITH U.S. ENTREPRENEURS EXPANDING ACCESS TO HEALTHCARE</title>
<link>https://6ix.com/company/reckitt-benckiser-group-plc/news/reckitt-catalyst-and-serena-williams-headline-sxswr-with-us-entrepreneurs-expanding-access-to-healthcare</link>
<guid isPermaLink="true">https://6ix.com/company/reckitt-benckiser-group-plc/news/reckitt-catalyst-and-serena-williams-headline-sxswr-with-us-entrepreneurs-expanding-access-to-healthcare</guid>
<pubDate>Fri, 13 Mar 2026 11:34:00 GMT</pubDate>
<description>Today, Reckitt, the company behind some of the world's most trusted health and hygiene brands, brings two newly named U.S. entrepreneurs from its Reckitt Catalyst program to the South by Southwest®(SXSW®) stage. They will appear alongside entrepreneur-in-residence Serena Williams for the featured session, "Breaking Barriers, Building Solutions: Meet the Entrepreneurs Transforming Health Innovation," a conversation about the systemic barriers founders navigate as they work to expand access to car</description>
</item>
<item>
<title>Directorate change</title>
<link>https://6ix.com/company/reckitt-benckiser-group-plc/news/directorate-change-363</link>
<guid isPermaLink="true">https://6ix.com/company/reckitt-benckiser-group-plc/news/directorate-change-363</guid>
<pubDate>Thu, 05 Mar 2026 07:01:00 GMT</pubDate>
<description>Reckitt Benckiser Group plc announces significant Directorate changes with the appointment of Harry Kirsch, former CFO of Novartis Pharma AG, and Deepak Nath, CEO of Smith+Nephew plc, as Non-Executive Directors effective April 1, 2026, while Margherita Della Valle and Mahesh Madhavan will retire from the Board on the same date. Harry Kirsch, who brings extensive finance experience from Novartis and Procter & Gamble, will also join the Audit Committee from May 2026. Deepak Nath's appointment adds</description>
</item>
<item>
<title>RESULTS FOR THE YEAR ENDED 31 DECEMBER 2025</title>
<link>https://6ix.com/company/reckitt-benckiser-group-plc/news/results-for-the-year-ended-31-december-2025</link>
<guid isPermaLink="true">https://6ix.com/company/reckitt-benckiser-group-plc/news/results-for-the-year-ended-31-december-2025</guid>
<pubDate>Thu, 05 Mar 2026 07:00:00 GMT</pubDate>
<description>Reckitt Benckiser Group plc has released its full-year results for the period ending 31 December 2025, proposing a final dividend of 127.8 pence, which brings the total 2025 dividend to 212.2 pence, a 5.0% increase from the previous year's 202.1 pence, aligning with the company's policy of progressive dividend growth. The company will host an investor presentation and Q&A session on 5 March 2026 at The London Stock Exchange.
Disclaimer*</description>
</item>
<item>
<title>Total Voting Rights</title>
<link>https://6ix.com/company/reckitt-benckiser-group-plc/news/total-voting-rights-85</link>
<guid isPermaLink="true">https://6ix.com/company/reckitt-benckiser-group-plc/news/total-voting-rights-85</guid>
<pubDate>Mon, 02 Mar 2026 14:33:00 GMT</pubDate>
<description>As of February 27, 2026, Reckitt Benckiser Group plc has 674,005,752 ordinary shares issued and admitted to trading, with each share carrying one vote. The company holds 29,043,683 ordinary shares in treasury, which have suspended voting rights. Consequently, the total number of voting rights available to shareholders is 644,962,069, serving as the denominator for notification obligations under the FCA's Disclosure Guidance and Transparency Rules.
Disclaimer*</description>
</item>
<item>
<title>Consumer Analyst Group of New York Conference 2026</title>
<link>https://6ix.com/company/reckitt-benckiser-group-plc/news/consumer-analyst-group-of-new-york-conference-2026</link>
<guid isPermaLink="true">https://6ix.com/company/reckitt-benckiser-group-plc/news/consumer-analyst-group-of-new-york-conference-2026</guid>
<pubDate>Thu, 19 Feb 2026 07:00:00 GMT</pubDate>
<description>Reckitt announced that its CEO and CFO will present at the Consumer Analyst Group of New York (CAGNY) Conference 2026, but confirmed that no new material financial or trading information will be disclosed during the event. The presentation is scheduled to take place today and will be audio live-streamed, with a replay available afterwards on the company's website.
Disclaimer*</description>
</item>
<item>
<title>COMPLETION OF 2ND TRANCHE OF SHARE BUYBACK</title>
<link>https://6ix.com/company/reckitt-benckiser-group-plc/news/completion-of-2nd-tranche-of-share-buyback</link>
<guid isPermaLink="true">https://6ix.com/company/reckitt-benckiser-group-plc/news/completion-of-2nd-tranche-of-share-buyback</guid>
<pubDate>Mon, 02 Feb 2026 07:00:00 GMT</pubDate>
<description>Reckitt Benckiser Group plc has completed the second tranche of its £1 billion share buyback programme, purchasing 3,461,470 ordinary shares between October 22, 2025, and January 28, 2026, at an average price of £59.46 per share. The company also announced the cancellation of 30 million ordinary shares on December 16, 2025, and an additional 14 ordinary shares on January 13, 2026, and no longer intends to cancel further treasury shares in connection with this tranche.
Disclaimer*</description>
</item>
<item>
<title>SHARE CONSOLIDATION EFFECTIVE & TOTAL VOTING RIGHT</title>
<link>https://6ix.com/company/reckitt-benckiser-group-plc/news/share-consolidation-effective-and-total-voting-right</link>
<guid isPermaLink="true">https://6ix.com/company/reckitt-benckiser-group-plc/news/share-consolidation-effective-and-total-voting-right</guid>
<pubDate>Mon, 02 Feb 2026 07:00:00 GMT</pubDate>
<description>Reckitt Benckiser Group plc announces that its Share Consolidation is effective today, February 2, 2026, following shareholder approval for a Special Dividend. The company's issued share capital will now consist of 674,005,752 ordinary shares, with 29,252,346 held in treasury, resulting in a total of 644,753,406 voting rights. This figure will serve as the denominator for shareholders calculating their notification obligations under FCA rules.
Disclaimer*</description>
</item>
<item>
<title>Transaction in Own Shares</title>
<link>https://6ix.com/company/reckitt-benckiser-group-plc/news/transaction-in-own-shares-121</link>
<guid isPermaLink="true">https://6ix.com/company/reckitt-benckiser-group-plc/news/transaction-in-own-shares-121</guid>
<pubDate>Thu, 29 Jan 2026 07:00:00 GMT</pubDate>
<description>Reckitt Benckiser Group plc has purchased 58,785 of its ordinary shares on January 28, 2026, at a volume weighted average price of 5,953.57 pence per share, with the highest price paid being 5,986.00 pence and the lowest at 5,922.00 pence. These repurchased shares will be held in treasury, bringing the total number of shares held in treasury to 30,471,194 and the total number of ordinary shares in issue, excluding treasury shares, to 671,618,131. This transaction impacts the total number of voti</description>
</item>
<item>
<title>Result of General Meeting</title>
<link>https://6ix.com/company/reckitt-benckiser-group-plc/news/result-of-general-meeting-26</link>
<guid isPermaLink="true">https://6ix.com/company/reckitt-benckiser-group-plc/news/result-of-general-meeting-26</guid>
<pubDate>Tue, 27 Jan 2026 09:00:00 GMT</pubDate>
<description>Reckitt Benckiser Group plc announced that all resolutions proposed at its General Meeting on January 27, 2026, were passed by poll. Key resolutions included the declaration of a special dividend of 235 pence per ordinary share, approved with 99.99% of votes for, and a share consolidation, approved with 99.96% of votes for. Directors' authorities to allot shares and disapply pre-emption rights were also renewed, with the latter approved for up to 5% of issued share capital by 99.36% and an addit</description>
</item>
<item>
<title>Response to Inaccurate Media Article</title>
<link>https://6ix.com/company/reckitt-benckiser-group-plc/news/response-to-inaccurate-media-article</link>
<guid isPermaLink="true">https://6ix.com/company/reckitt-benckiser-group-plc/news/response-to-inaccurate-media-article</guid>
<pubDate>Mon, 26 Jan 2026 10:41:00 GMT</pubDate>
<description>Reckitt Benckiser Group plc has issued a statement to address an inaccurate media article claiming a product recall in the Philippines. The company confirms that the Mead Johnson Nutrition product, Enfamil ProSobee Simply Plant-Based Infant Formula, is not registered or marketed in the Philippines, and therefore, no such recall has occurred. This clarification is important for investors and analysts to understand the company's operational status and product distribution.
Disclaim</description>
</item>
<item>
<title>Special Dividend and Share Consolidation</title>
<link>https://6ix.com/company/reckitt-benckiser-group-plc/news/special-dividend-and-share-consolidation</link>
<guid isPermaLink="true">https://6ix.com/company/reckitt-benckiser-group-plc/news/special-dividend-and-share-consolidation</guid>
<pubDate>Wed, 07 Jan 2026 07:00:00 GMT</pubDate>
<description>Reckitt Benckiser Group plc has published a circular detailing a proposed special dividend of 235 pence per ordinary share, amounting to approximately £1.6 billion, to be paid following the divestment of its Essential Home business. This dividend, in addition to ongoing buybacks and ordinary dividends, will be accompanied by a 24 for 25 share consolidation, aiming to maintain market capitalization. Shareholders will vote on these proposals at a general meeting on January 27, 2026, with the speci</description>
</item>
<item>
<title>Completion of Divestment</title>
<link>https://6ix.com/company/reckitt-benckiser-group-plc/news/completion-of-divestment</link>
<guid isPermaLink="true">https://6ix.com/company/reckitt-benckiser-group-plc/news/completion-of-divestment</guid>
<pubDate>Wed, 31 Dec 2025 10:17:00 GMT</pubDate>
<description>Reckitt Benckiser Group plc has completed the divestment of its Essential Home business to Advent International, L.P., retaining a 30% equity stake in the acquisition vehicle. Reckitt anticipates returning approximately US$2.2 billion to shareholders via a special dividend and share consolidation, details of which are expected around January 7, 2026, in addition to its ongoing share buyback program and ordinary dividend policy. This strategic move aims to simplify Reckitt's operations and focus </description>
</item>
<item>
<title>Transaction in Own Shares & Share Cancellation</title>
<link>https://6ix.com/company/reckitt-benckiser-group-plc/news/transaction-in-own-shares-and-share-cancellation</link>
<guid isPermaLink="true">https://6ix.com/company/reckitt-benckiser-group-plc/news/transaction-in-own-shares-and-share-cancellation</guid>
<pubDate>Tue, 16 Dec 2025 07:00:00 GMT</pubDate>
<description>Reckitt Benckiser Group plc has purchased 58,420 ordinary shares at a volume weighted average price of 5,990.24 pence per share, with the highest price paid being 6,014.00 pence and the lowest 5,942.00 pence. Concurrently, the company has cancelled 30,000,000 ordinary shares held in treasury, resulting in 29,575,317 shares remaining in treasury and a total of 672,514,022 voting rights in issue. This updated total number of voting rights will serve as the denominator for shareholders calculating </description>
</item>
<item>
<title>‘RECKITT FOCUS ON’ INVESTOR SEMINAR</title>
<link>https://6ix.com/company/reckitt-benckiser-group-plc/news/reckitt-focus-on-investor-seminar</link>
<guid isPermaLink="true">https://6ix.com/company/reckitt-benckiser-group-plc/news/reckitt-focus-on-investor-seminar</guid>
<pubDate>Thu, 04 Dec 2025 07:00:00 GMT</pubDate>
<description>Reckitt Benckiser Group PLC announced an investor seminar focused on Emerging Markets, aiming to provide insights into their strategy for driving sustainable high-single-digit like-for-like net revenue growth in these regions, which contributes to the company's medium-term guidance of +4% to +5% like-for-like net revenue growth for Core Reckitt. The company stated that no new material financial or trading information would be disclosed during the event.
Disclaimer*</description>
</item>
<item>
<title>Director/PDMR Shareholding</title>
<link>https://6ix.com/company/reckitt-benckiser-group-plc/news/directorpdmr-shareholding-196</link>
<guid isPermaLink="true">https://6ix.com/company/reckitt-benckiser-group-plc/news/directorpdmr-shareholding-196</guid>
<pubDate>Thu, 30 Oct 2025 07:05:00 GMT</pubDate>
<description>On October 30, 2025, Reckitt Benckiser Group PLC announced a director/PDMR shareholding notification. Non-Executive Director Pat Verduin purchased 135 ordinary shares at a price of £58.67 per share on October 29, 2025. The transaction, executed on the London Stock Exchange, Main Market - XLON, resulted in an aggregate total of £7,920.45. This was an initial notification.
Disclaimer*</description>
</item>
<item>
<title>Commencement of Second Tranche of Share Buyback</title>
<link>https://6ix.com/company/reckitt-benckiser-group-plc/news/commencement-of-second-tranche-of-share-buyback</link>
<guid isPermaLink="true">https://6ix.com/company/reckitt-benckiser-group-plc/news/commencement-of-second-tranche-of-share-buyback</guid>
<pubDate>Wed, 22 Oct 2025 06:30:00 GMT</pubDate>
<description>Reckitt Benckiser Group PLC announced the completion of the first tranche of its 2025 share buyback program. Under the first tranche, the company purchased 4,445,840 ordinary shares at an average price of £56.23, for a total of £250 million, and these shares have been cancelled. The company will commence the second tranche of the Programme on 22 October 2025, intending to return a further up to £250 million of capital to shareholders, concluding on or before 30 January 2026. The maximum number o</description>
</item>
<item>
<title>Reckitt Q3 2025 Trading Update</title>
<link>https://6ix.com/company/reckitt-benckiser-group-plc/news/reckitt-q3-2025-trading-update</link>
<guid isPermaLink="true">https://6ix.com/company/reckitt-benckiser-group-plc/news/reckitt-q3-2025-trading-update</guid>
<pubDate>Wed, 22 Oct 2025 06:00:00 GMT</pubDate>
<description>Reckitt Benckiser Group PLC reported strong Q3 2025 results, with Group LFL net revenue up 7.0% to £3,611 million and Core Reckitt LFL net revenue increasing by 6.7% to £2,603 million. Emerging Markets saw a significant LFL net revenue increase of 15.5% to £1,080 million, while Europe returned to growth with a 0.8% increase to £865 million and North America grew by 1.3% to £658 million. Mead Johnson Nutrition's LFL net revenue grew by 22.0% to £529 million, while Essential Home declined by 4.9% </description>
</item>
</channel>
</rss>